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BOSTON – Governor Charlie Baker today joined Health and Human Services Secretary Marylou Sudders 
and leaders of health care advocacy organizations for a ceremonial signing of key sections of the Fiscal 
Year 2020 (FY20) budget that aim to create health care savings for individuals and the Commonwealth. 
The Governor and Secretary were joined by Amy Rosenthal, Executive Director of Health Care for All 
(HCFA), and Edna Pruce, President of the Mass. Senior Action Council (MSAC) and several older adults 
affiliated with MSAC. 
    
The ceremonial bill signing marks the enactment of two sections of the FY 2020 budget: (1) reforms that 
allow MassHealth to directly negotiate with drug manufacturers, establishing enhanced accountability 
and transparency of drug prices and incorporating drug manufacturers into public processes similar to 
those that already exist for health care providers and health plans in Massachusetts; and (2) a measure 
that authorizes expanded eligibility for the Medicare Savings Program, which will bring more than $100 
million in federal subsidies directly to roughly 40,000 low income older adults and people with 
disabilities to significantly reduce their health care costs. 
    
“These sections of the FY20 budget make important reforms that aim to reduce prescription drug costs 
and expand eligibility for the Medicare Savings Program,” said Governor Charlie Baker. “We are 
grateful for our partners in the advocacy community and in the Legislature for working with us to enact 
these important initiatives.” 
    
“By enacting these reforms to enable MassHealth to negotiate directly with drug manufacturers and 
implementing a public accountability process, we have created a framework to make a real difference 
when it comes to controlling rising drug costs,” said Health and Human Services Secretary Marylou 
Sudders. “Additionally, expanding eligibility to the Medicare Savings Program will significantly reduce 
health care costs for tens of thousands of individuals, providing thousands of dollars in out-of-pocket 
savings and promoting economic security.” 
    
“Health Care For All frequently hears from community members and HelpLine callers who are struggling 
to afford the medications they need. We also know that MassHealth, a program that is critical for our 
most vulnerable residents, has seen a near doubling of prescription drug costs in just five years,” said 
Amy Rosenthal, Executive Director of Health Care For All. “Giving MassHealth the tools they need to 
negotiate lower drug costs makes Massachusetts a national leader. We are very thankful to Governor 
Baker and Secretary Sudders for their leadership and partnership in getting this important provision 
over the finish line. We also deeply appreciate the work of  legislative leaders and the budget conferees. 
We look forward to implementing this provision and taking the next steps to bring down prescription 
drug costs for those with private insurance.” 
    
“No senior should have to choose between the cost of medication and the food they need. 
Unfortunately, that is the case for far too many across the Commonwealth,” said Edna Pruce, President 
of the Mass. Senior Action Council. “This is a historic moment because expanding the Medicare Savings 
Programs will go a long way to change that for 40,000 seniors. We look forward to continuing work with 
Governor Baker and Secretary Sudders to strengthen the health and economic well-being of all seniors 
in Massachusetts.” 
    
FY20 Budget Health Care Measures 
 
MassHealth Pharmacy Reforms 
Through reforms proposed by the Baker-Polito Administration and enacted by the Legislature, the FY20 
budget authorizes MassHealth to directly negotiate with drug manufacturers while maintaining 
coverage for members. The reforms establish enhanced accountability and transparency of drug prices 
and incorporate drug manufacturers into public processes similar to those that already exist for health 
care providers and health plans in Massachusetts. 
    
The reforms give MassHealth greater negotiating leverage for prescription drug prices, including 
authority to engage in: 
    
 Direct Negotiations: Gives MassHealth authority to negotiate supplemental rebate agreements, 
including value- or outcomes-based contracts, directly with drug manufacturers. 
 Public Process: If direct negotiations are unsuccessful and the drug costs at least $25K person/year 
or $10M in the aggregate annually, MassHealth can establish a target value for a given high-cost 
drug through a public process, similar to the rate-setting process that exists for most other services 
that MassHealth covers.  
 Health Policy Commission (HPC) Accountability Process: The reforms also leverage features of 
existing HPC processes and oversight tools for health care providers and payers to hold drug 
manufacturers more accountable. 
    
Additionally, MassHealth is implementing requirements to limit and make more transparent Pharmacy 
Benefit Manager (PBM) margins and “spread pricing” within its ACOs and MCOs. Together, these 
MassHealth pharmacy initiatives are projected to save the Commonwealth $80 million in FY20.   
     
Medicare Savings Program Changes 
Through reforms proposed by the Baker-Polito Administration and enacted by the Legislature, the FY20 
budget authorized expanded eligibility for the Medicare Savings Program.  
     
The Medicare Savings Program (MSP), also known as “MassHealth Buy-In”, helps low-income older 
adults and people with disabilities pay for their health care costs. Under the MSP, MassHealth and the 
federal government share the cost of assisting older adults and people with disabilities with premiums 
and out-of-pocket costs in Medicare Parts A and B, which cover hospital and medical services. MSP 
participants also automatically qualify for federal subsidies for pharmacy coverage through Medicare 
Part D, which eliminate premiums, deductibles, and most cost-sharing. 
    
Starting January 1, 2020, income eligibility will be expanded for the MSP program from 135% FPL to 
165% FPL and the asset limit for MSP will be doubled. The expansion will significantly reduce Medicare 
costs for ~40,000 individuals, providing thousands of dollars in out-of-pocket savings on average per 
year to promote economic security. 
    
The expansion generates over $100 million in federal subsidies that will flow directly to low income 
older adults and people with disabilities, with a new state investment of $7 million net annually ($4 
million in FY20). The $100M in federal subsidies directly to older adults and individuals with disabilities 
comes from increasing the number of individuals eligible for federal Medicare Part D subsidies. 
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